CIK 0001799448
- Non-accelerated filer
- Smaller reporting company
Aligos Therapeutics, Inc.
Sign in to watch- Ticker
- ALGS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 800-466-6059
- Business address
- ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-20 | Woiwode Thomas Director | Conversion · Series A Preferred Stock | −2,145,991 | 0 | ||
| 2020-10-20 | Woiwode Thomas Director | Conversion · Series B-1 Preferred Stock | −198,839 | 0 | ||
| 2020-10-20 | Woiwode Thomas Director | Conversion · Series B-1 Preferred Stock | −463,959 | 0 | ||
| 2020-10-20 | Woiwode Thomas Director | Conversion · Series B-2 Preferred Stock | −85,065 | 0 | ||
| 2020-10-20 | Woiwode Thomas Director | Conversion · Series B-2 Preferred Stock | −198,485 | 0 |
Page 2 of 2 · 25 trades